IPG vs RIGL
IPG (IPG) versus Rigel Pharmaceuticals Inc (RIGL) — a side-by-side from cached financials, not a winner call.
IPG (IPG) common stock.
Rigel Pharmaceuticals Inc (RIGL) is a biotechnology company listed on US.
IPG does not have a complete income-statement cache yet.
Latest reported RIGL revenue for 2024-12-31 was $179.3M. Net income was $17.5M. Revenue was up 53.4% from 2023-12-31 to 2024-12-31. RIGL currently screens at market cap $338.3M and trailing P/E 9.1.
RIGL currently screens at market cap $338.3M and trailing P/E 9.1.
Not investment advice. Open the IPG and RIGL stock pages for the full models.
Not investment advice.